跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
N-40
首页
药物
N-40
N-40
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
BIOCOMPATIBLE AND BIOABSORBABLE DERIVATIZED CHITOSAN COMPOSITIONS
EP 3569262 A1
申请人: TRICOL BIOMEDICAL INC
优先权: 2013
CN
EP
US
8 件公开
PERFUSION COMPOSITION
EP 2611291 B1
申请人: PERFUSION FLUID TECH INC
优先权: 2011
EP
US
WO
7 件公开
Nutritional supplement
US 2009061023 A1
申请人: ALBRITTON IV FORD D
优先权: 2007
US
WO
6 件公开
COMBINATION SOLID ORAL DOSAGE FORMS OF GONADOTROPIN-RELEASING HORMONE ANTAGONISTS
EP 4157227 A1
申请人: MYOVANT SCIENCES GMBH
优先权: 2020
CN
EP
US
WO
5 件公开
POLYOLEFIN, PLASTICIZER FOR ELECTRONIC MATERIAL, SUBSTRATE FOR COSMETIC PREPARATION, COSMETIC PREPARATION, AND LUBRICATING AGENT
US 20250257157 A1
申请人: NOF CORP
优先权: 2022
CN
EP
US
WO
4 件公开
Conjugation process for PNAG and a carrier protein
US 8933218 B2
申请人: BIEMANS RALPH LEON
优先权: 2007
US
4 件公开
Pyro-glutamate Abeta targeting agents
US 8512677 B2
申请人: DEALWIS CHRIS
优先权: 2010
US
4 件公开
Non-aqueous pharmaceutical composition
US 8946208 B2
申请人: CASTILE JONATHAN
优先权: 2007
CN
US
3 件公开
Compounds for treating amyloidoses
US 8409581 B2
申请人: MANDLER MARKUS
优先权: 2008
CN
US
3 件公开
NOVEL SURFACTANT-FREE SELF-REVERSIBLE REVERSE LATEX, AND USE OF SAME AS A THICKENING AGENT IN A COSMETIC COMPOSITION
US 2015098915 A1
申请人: MALLO PAUL
优先权: 2012
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈